Peter Libby

14.4k total citations
6 papers, 845 citations indexed

About

Peter Libby is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peter Libby has authored 6 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Surgery, 2 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peter Libby's work include Protease and Inhibitor Mechanisms (2 papers), Atherosclerosis and Cardiovascular Diseases (2 papers) and Viral Infections and Immunology Research (1 paper). Peter Libby is often cited by papers focused on Protease and Inhibitor Mechanisms (2 papers), Atherosclerosis and Cardiovascular Diseases (2 papers) and Viral Infections and Immunology Research (1 paper). Peter Libby collaborates with scholars based in United States, Sweden and Brazil. Peter Libby's co-authors include Galina K. Sukhova, Richard N. Mitchell, Seigo Sugiyama, Yoshihiro Fukumoto, Elena Rabkin, Masanori Aikawa, Koïchi Shimizu, Paul M. Ridker, Anders Grubb and Harold A. Chapman and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and European Heart Journal.

In The Last Decade

Peter Libby

6 papers receiving 833 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Libby United States	5	325	301	208	192	142	6	845
Pilar Sandoval Spain	21	495 1.5×	420 1.4×	260 1.3×	207 1.1×	156 1.1×	37	1.4k
B Descamps France	14	224 0.7×	609 2.0×	64 0.3×	358 1.9×	113 0.8×	29	1.1k
Per Reidar Woldbæk Norway	12	114 0.4×	277 0.9×	136 0.7×	110 0.6×	225 1.6×	16	757
Thomas E. Palmer United States	9	159 0.5×	260 0.9×	87 0.4×	85 0.4×	66 0.5×	13	723
S Fuggle United Kingdom	15	393 1.2×	458 1.5×	165 0.8×	208 1.1×	354 2.5×	25	1.2k
Solène Evrard France	17	204 0.6×	232 0.8×	85 0.4×	99 0.5×	86 0.6×	37	748
S Katsuda Japan	15	223 0.7×	162 0.5×	230 1.1×	193 1.0×	176 1.2×	21	927
Christopher Franco Canada	12	143 0.4×	155 0.5×	98 0.5×	166 0.9×	119 0.8×	18	773
Wolfgang Röckl Germany	8	115 0.4×	718 2.4×	116 0.6×	172 0.9×	122 0.9×	10	1.0k
Óscar Busnadiego Spain	12	121 0.4×	309 1.0×	195 0.9×	102 0.5×	74 0.5×	12	761

Countries citing papers authored by Peter Libby

Since Specialization

Citations

This map shows the geographic impact of Peter Libby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Libby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Libby more than expected).

Fields of papers citing papers by Peter Libby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Libby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Libby. The network helps show where Peter Libby may publish in the future.

Co-authorship network of co-authors of Peter Libby

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Libby. A scholar is included among the top collaborators of Peter Libby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Libby. Peter Libby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Ridker, Paul M., Jean MacFadyen, Tom Thurén, & Peter Libby. (2019). 2417Elevated interleukin-6 and interleukin-18 concentrations predict residual inflammatory risk both before and after interleukin-1beta inhibition with canakinumab. European Heart Journal. 40(Supplement_1). 10 indexed citations

2.

Libby, Peter, Robert J. Glynn, Tom Thurén, Robert Hilkert, & Paul M. Ridker. (2018). 358Understanding and mitigating the risk of infection with canakinumab. European Heart Journal. 39(suppl_1). 2 indexed citations

3.

Shimizu, Koïchi, Seigo Sugiyama, Masanori Aikawa, et al.. (2001). Host bone-marrow cells are a source of donor intimal smooth- muscle–like cells in murine aortic transplant arteriopathy. Nature Medicine. 7(6). 738–741. 394 indexed citations

4.

Shi, Guo-Ping, Galina K. Sukhova, Anders Grubb, et al.. (1999). Cystatin C deficiency in human atherosclerosis and aortic aneurysms. Journal of Clinical Investigation. 104(9). 1191–1197. 351 indexed citations

5.

Higuchi, Maria de Lourdes, et al.. (1999). HISTOLOGICAL EVIDENCE OF CONCOMITANT INTRAMYOCARDIAL AND EPICARDIAL VASCULITIS IN NECROPSIED HEART ALLOGRAFTS. Transplantation. 67(12). 1569–1576. 14 indexed citations

6.

Libby, Peter, Galina K. Sukhova, Richard Lee, & James K. Liao. (1997). Molecular biology of atherosclerosis. International Journal of Cardiology. 62. S23–S29. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact